Jess Wiggs 5/1/22 Jess Wiggs 5/1/22

FRONTLINE HEALTHCARE PROVIDERS IN THE PHILIPPINES ASSERT THE HIGH ACCEPTABILITY OF THE BPAL REGIMEN

Jess Wiggs 4/7/22 Jess Wiggs 4/7/22

Launch of LIFT-TB in Indonesia

Jess Wiggs 3/24/22 Jess Wiggs 3/24/22

LIFT-TB Partners Join TB Alliance in Advancing the Treatment of Drug-Resistant Tuberculosis on World TB Day

Jess Wiggs 3/4/22 Jess Wiggs 3/4/22

LIFT-TB Partners Provide Support to Technical and Coordinating Bodies To Support Proper Use of New Regimen

Jess Wiggs 10/20/21 Jess Wiggs 10/20/21

TB Alliance Welcomes New Data on BPaL-Based Regimens Presented at the 2021 Union Conference

Jess Wiggs 8/16/21 Jess Wiggs 8/16/21

The Philippines enrolls first patient with highly drug-resistant TB on the BPaL regimen (acknowledgment: Dr. Irene Flores)

Jess Wiggs 7/15/21 Jess Wiggs 7/15/21

New Trial Results Show Effectiveness of BPaL Regimen for Highly Drug-Resistant TB Can Be Maintained with Reduced Dosing of Linezolid

Jess Wiggs 7/8/21 Jess Wiggs 7/8/21

Research Team Spearheads the Implementation of The BPaL Operational Research in the Philippines

Jess Wiggs 12/16/20 Jess Wiggs 12/16/20

LIFT-TB Philippines launched to commence the operational research using the BPaL Regimen

Jess Wiggs 10/21/20 Jess Wiggs 10/21/20

TB Alliance with the Support of the Republic of Korea Announce Initiative to Broaden Adoption and Scale Up of New Treatments for Drug-Resistant Tuberculosis (TB)